NACURE 5225 is an amine neutralized Dodecylbenzenesulfonic acid (DDBSA) catalyst. Advantages over blocked p-TSA catalysts are viscosity stability and solubility.
| % Active | 25 |
| Formulation Advantage | Blocked, Solubility, Stability |
| Application Advantage | Exterior durability |
| Market Application | Auto OEM, Can, General industrial |
| Product Group | Catalyst (acid) |
Related Products
-
NACURE 5076
% Active 70Formulation Advantage SolubilityApplication Advantage Exterior durabilityCatalyst (acid)Complies with FDA 21 CFR, Sec. 175.300 (b) (3) xii & xiii (a&b). -
NACURE 5925
% Active 25Application Advantage FDA approvableFormulation Advantage BlockedCatalyst (acid)Complies with FDA 21 CFR, Sec. 175.300 (b) (3) xii & xiii (a&b). -
NACURE 5528
% Active 25Formulation Advantage BlockedApplication Advantage Exterior durabilityCatalyst (acid)Broad solubility and excellent color stability.
Recently Viewed Products
-
NACURE CD-2180
Market Application XLPE SystemsApplication Advantage Ambient cureFormulation Advantage CompatibilityCatalyst (acid)A proprietary hydrophobic sulfonic acid catalyst. It is highly effective for the hydrolysis of siloxane functional polymers at ambient conditions. -
NACURE 5925
% Active 25Application Advantage FDA approvableFormulation Advantage BlockedCatalyst (acid)Complies with FDA 21 CFR, Sec. 175.300 (b) (3) xii & xiii (a&b).